NCT01889966View on ClinicalTrials.gov

VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Pulmonary Hypertension Associated With Connective Tissue Disease
Interventions
DRUG

Sildenafil

oral Sildenafil 3 x 20 mg for 90 days

Trial Locations (1)

61231

Kerckhoff Heart Center, Bad Nauheim

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Kerckhoff Heart Center

OTHER